UK Markets open in 4 hrs 28 mins

Biogen Inc. (BIIB.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
4,067.33+46.33 (+1.15%)
At close: 02:58PM CDT
Full screen
Previous close4,021.00
Bid4,067.33 x 100
Ask0.00 x 100
Day's range4,067.33 - 4,067.33
52-week range3,880.00 - 7,356.00
Avg. volume55
Market cap607.984B
Beta (5Y monthly)0.44
PE ratio (TTM)19.40
EPS (TTM)209.61
Earnings date20 Apr 2022 - 25 Apr 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital Platform

    CAMBRIDGE, Mass. & NEW YORK, June 22, 2022--Biogen (NASDAQ:BIIB) and Happify Health (, the Intelligent Healing Company™, today announced a collaboration to provide a digital solution for patient education and engagement, powered by artificial intelligence (AI), to support people living with multiple sclerosis (MS). Through this collaboration, Biogen and Happify Health will help people with MS manage their care journey, improve their wellbeing, learn about treatment options,

  • Zacks

    Ionis (IONS), AstraZeneca's Amyloidosis Drug Meets Study Goals

    Ionis (IONS), along with partner AstraZeneca, reports positive data from a phase III study, which is evaluating eplontersen in hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).

  • Zacks

    Roche Alzheimer's Candidate Failure Hurts Lilly, Biogen

    Eli Lilly (LLY) and Biogen's (BIIB) Alzheimer's candidates, anti-amyloid beta antibodies, are in late-stage development and are expected to be launched in a few months.